Skip to main content
Caplight Logo









YouthBio Therapeutics

YouthBio Therapeutics

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://youthbiotx.com

Total Funding Raised

$1.7M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

YouthBio Therapeutics operates in Healthcare & Life Sciences and is based in Seattle, Washington. It has raised $1.7M.

YouthBio Therapeutics is a biotechnology company that develops tissue-specific gene therapies using partial cellular reprogramming to treat age-related diseases, with an initial focus on Alzheimer's.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B2C

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

YouthBio Therapeutics Comparables

Compare YouthBio Therapeutics with similar companies based on industry and business-model similarity.

YouthBio Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Turn Biotechnologies
79%
Rejuvenate Bio
77%
Renue Life Sciences, Inc.
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

YouthBio Therapeutics Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for YouthBio Therapeutics. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Yuri Deigin

Co-Founder And CEO

Founding Team

Joao Pedro de Magalhaes

Chief Scientific Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 101% MoM, reaching 1K.

  • May 20, 2026

    Monthly visitors grew 99% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

YouthBio Therapeutics Filings

Explore SEC and related filing metadata, where available.

YouthBio Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about YouthBio Therapeutics's valuation, stock price, and market status.

Is YouthBio Therapeutics a public or private company?

YouthBio Therapeutics is a private company.

What is the current stock price of YouthBio Therapeutics?

YouthBio Therapeutics is a private company, so its shares have no public market price. Caplight tracks YouthBio Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is YouthBio Therapeutics worth (valuation)?

Valuation information for YouthBio Therapeutics is not publicly available.

Can I buy YouthBio Therapeutics stock?

YouthBio Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was YouthBio Therapeutics's last funding round?

Funding round information for YouthBio Therapeutics is not publicly available.

Who are the main investors in YouthBio Therapeutics?

Investor information for YouthBio Therapeutics is not publicly disclosed.

Will YouthBio Therapeutics IPO soon?

No public IPO plans have been announced for YouthBio Therapeutics.

How can I track YouthBio Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades in YouthBio Therapeutics's shares on secondary markets.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range2
Year Founded2021
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?